课题基金 / 基金详情

Development and evaluation of a recombinant porcine adenovirus vaccine for post-exposure protection against Ebolavirus

Development and evaluation of a recombinant porcine adenovirus vaccine for post-exposure protection against Ebolavirus
用于埃博拉病毒暴露后保护的重组猪腺病毒疫苗的开发和评估
批准号：
206242
负责人：
Wong Gary C
金额：
$7.65万
依托单位：
University of Manitoba
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2009
资助国家：
加拿大
项目状态：
已结题
起止时间：
2009-10-01 至 2012-10-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=206242&lang=en
关键词：
Adaptive Immune Response Animal Models Ebolavirus Human Innate Level Iv Biocontainment Porcine Adenovirus Post-Exposure Protection Pre-Existing Immunity Recombinant Viruses Reverse Genetics Vaccine Design

项目摘要

项目成果

Wong Gary C的其他基金

相似基金

相关文献

中文摘要
翻译
埃博拉病毒（EBOV）自发现以来已造成毁灭性疾病，主要在非洲，死亡率高达90%。 由于人类自然暴发的频繁发现及其作为生物医学的适宜性，
英文摘要
Ebolavirus (EBOV) has caused devastating disease since its discovery, primarily in Africa with a death rate reaching up to 90%. It has also drawn increasing global attention due to frequent detection of natural human outbreaks and its suitability as a bi
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Structural characterization and optimization of ZMapp, an antibody cocktail efficacious against Ebola virus in nonhuman primates
Persistent infection and restimulation of Ebolavirus from dormancy in African fruit bats
海外基金